Advocacy

Washington Update: Recent Executive Actions and Implications for Biomedical Research and Health

Washington Update: Recent Executive Actions and Implications for Biomedical Research and Health

The first two months of the Trump Administration have seen significant actions shaping the 2025 legislative and policy landscape, particularly for fiscal negotiations in science, education, and academic medicine. Policymakers must navigate differing priorities and perspectives, which complicates negotiations to ensure continued operation of the federal government. Due to this environment, the impact on biomedical... Read More

Washington Update: Post-Election Outcomes and Impacts to Biomedical Research

Washington Update: Post-Election Outcomes and Impacts to Biomedical Research

Just a few days after winning the election, the incoming Trump Administration began to identify key health policy proposals. Some of these priorities include addressing mental health issues and tackling the opioid overdose crisis, accelerating translational research, and improving rural health. The National Institutes of Health (NIH) remains under scrutiny, with ongoing discussions surrounding its... Read More

Capitol building in Washington DC in summer day

Washington Update: Congress Returns from August Recess with Remaining FY25 Funding Bills to Advance; 2024 Elections to Bring Implications for Science

This summer, Congress navigated many complex priorities as lawmakers prepared to return to their home districts for August recess. Notably, the House Appropriations Committee approved the fiscal year (FY) 2025 House Labor, Health and Human Services, and Education (L-HHS-ED) bill on a party-line vote. However, this bill still awaits a vote by the full U.S.... Read More

ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy